Project Grant COPC21940

The National Science Foundation (NSF) awarded a $305,000 STTR Phase I project grant to Sensvita Inc. under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a non-invasive radio frequency sensing technology for home-based monitoring of heart and lung function. The proposed system uses advanced sensing methods to measure critical physiological parameters without the need for skin contact or maintenance, improving the convenience, scalability,...

This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Makani Science Inc. will develop a continuous respiratory monitoring platform to accurately classify apnea of prematurity (AOP) in premature newborns. The $371,021 award will fund a two-phase effort to build a multimodal monitoring system and machine learning models to identify the major AOP types (central, obstructive, and mixed). The initial R61 phase will develop the...

The National Science Foundation (NSF) awarded a $550,000 Project Grant under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to the University of Missouri System to develop six-lead, wearable heart monitors using innovative, multifunctional, porous, soft materials. The project aims to enhance wearable heart monitors for improved cardiac health management by addressing current limitations in ambulatory ECG monitoring, such as motion-induced artifacts and limited...

Federal Project Grant Award Summary Linshom Medical, Inc. received a $322,277 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded on September 10, 2025, with completion targeted for August 31, 2027. The award funds clinical development and evaluation activities for Linshom's Continuous Predictive Respiratory Sensor (CPRS), an FDA-cleared medical device designed to enable early detection and...

This federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $117,750 to the Ann & Robert H Lurie Children's Hospital of Chicago to develop and implement a remote patient monitoring dashboard that links parents' real-time vital sign data and symptom reports to pediatric patients' electronic health records. The goal is to facilitate more informed, remote adjustments to ventilator settings for children dependent...

Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Florida Institute of Technology Inc. a Project Grant of $406,221.00 (Award Date: September 15, 2025; Completion Date: August 31, 2028) under the Cardiovascular Diseases Research program (CFDA 93.837) to develop a novel, low-cost, machine learning-based wearable technology for continuous monitoring of heart failure parameters. The research addresses a critical gap in remote cardiac monitoring by focusing on left...

This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to advance geriatric palliative care by assessing the feasibility and acceptability of using radio frequency (RF) sensors to capture cardiopulmonary measures in nursing home patients with Alzheimer's disease and related dementias (ADRD). The $451,721 award to Weill Medical College of Cornell University will also develop a machine learning algorithm to autonomously detect and predict respiratory...

Dynocardia Inc. received a $256,000 National Science Foundation Project Grant to advance development of a novel continuous, cuffless blood pressure monitoring device. Funded through the NSF Engineering Directorate's SBIR program, the award will support Dynocardia's efforts to address motion artifacts and enable accurate, beat-to-beat blood pressure measurements in hospital intensive care and operating room settings. Accurate 24-hour blood pressure monitoring has potential to significantly...

This $200,000 Project Grant awarded by the National Science Foundation (NSF) Division of Electrical, Communications and Cyber Systems under CFDA 47.041 (Engineering) aims to develop and implement a novel testing platform to evaluate the accuracy of wearable photoplethysmography-based blood pressure monitoring devices. The University of Maryland, College Park will construct a bench flow phantom that simulates physiologically relevant blood pressure, blood flow, anatomical, and optical...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $785,000 to the University of California, Irvine under the Cardiovascular Diseases Research program (CFDA 93.837) on September 1, 2025, with a completion date of July 31, 2026. This Project Grant funds development of the Maternal Obstetric Monitoring System (MOMS), a wearable device designed to enable early detection of postpartum hemorrhage (PPH)—the leading cause of death in pregnant women. The project...